A combination therapy of gemcitabine with immunotherapy for patients with inoperable locally advanced pancreatic cancer.
Mrz 2009 - Pancreas; 38(3):1536-4828 [PMID:19276867]
[Hirooka Y] [Itoh A] [Kawashima H] [Hara K] [Nonogaki K] [Kasugai T] [Ohno E] [Ishikawa T] [Matsubara H] [Ishigami M] [Katano Y] [Ohmiya N] [Niwa Y] [Yamamoto K] [Kaneko T] [Nieda M] [Yokokawa K] [Goto H]

Potential of dendritic-cell immunotherapy for relapse after allogeneic hematopoietic stem cell transplantation, shown by WT1 peptide- and keyhole-limpet-hemocyanin-pulsed, donor-derived dendritic-cell vaccine for acute myeloid leukemia.
Apr 2008 - Am. J. Hematol.; 83(4):1096-8652 [PMID:18081032]
[Kitawaki T] [Kadowaki N] [Kondo T] [Ishikawa T] [Ichinohe T] [Teramukai S] [Fukushima M] [Kasai Y] [Maekawa T] [Uchiyama T]